Aptamers Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025– Growing advancements in aptamers development technologies, increasing R&D expenditure and rising number of companies investing in this field are some of the key driving factors responsible for the growth of this market.

Aptamers Market was valued at USD 2142.8 Million in 2018 and is projected to reach around USD 7456.8 Million by 2025, at a CAGR of 19.50% during the forecast period.

Scope of Global Aptamers Market Report:–

Aptamers are single-stranded DNA or RNA (ssDNA or ssRNA) molecules. Aptamers are the oligonucleotide or peptide molecules that bind to a specific target molecule. Aptamers are multipurpose and cost effective, offers the complimentary or alternative solutions to the antibodies. Aptamers are attracted much attention recently for potential therapeutic and diagnostic purposes and have gained worldwide preferences over antibodies due to some of its key benefits such as lower cost, ability to not destroy neighboring cells, greater binding affinity, longer shelf life and high specificity.

Global Aptamers Market is segmented on the basis of type, applications, end-users and region & country level. Based upon type, global aptamers market is segmented into nucleic acid aptamers, DNA-based aptamers, RNA-based aptamers, XNA-based aptamers, and peptide aptamers. Based on applications, the aptamers market is segmented into diagnostics, therapeutics development, research and development, and others. Based upon end-user, global aptamers market is segmented into bio-pharmaceutical companies, pharmaceutical companies, academic and research centers, and contract research organization.

The regions covered in this aptamers market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of Aptamers is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

Browse The Full Report@ https://www.brandessenceresearch.com/healthcare/aptamers-market/

Key Players for Global Aptamers Market Reports–

Some major key players for global nutraceutical ingredients market are Aptamer Sciences, Inc., AMBiotech, Aptagen, LLC., Aptamer Group, Aptus Biotech, Base Pair Biotechnologies, Cambio, NeoVentures Biotechnology Inc., SOMALOGIC INC., TriLink BioTechnologies, LLC, Vivonics Inc., NOXXON Pharma, Ophthotech Corporation, 2bind, NOVAPTECH, Donovan, LLC, ATDBio Ltd., AuramerBio, Barrick Lab, Creative Biogene, AMS Biotechnology (Europe) Limited, IBA GmbH and Kaneka Corporation and others.

News:-

In August 2013, Aptamer Sciences Inc. entered into a distributorship agreement for distribution of AptSci product and services respectively. AMS Biotechnology (EU) ltd and its USA based subsidiary (AMSBIO LLC) should have broad marketing network coverage of Europe and USA, strong connections within academia in order to promote Aptamer Products and Services within the relevant academicals department. This agreement will position AMS Biotechnology and its USA based subsidiary (ANSBIO LLC) as the leading supplier of aptamer based products and services in Europe and USA.

Global Aptamers Market Dynamics –

Global aptamers market is expected to witness a positive growth owing to higher research and development activities and investment in pharmaceutical and biopharmaceutical companies. For instance, in 2017 Caris Life Sciences Indentifies New Mechanism of Action for an Aptamer with Therapeutic Potential to Treat Non-Hodgkin Lymphoma (ADAPT Biotargeting System TM). According to David Spetzler, Chief Scientific Officer of Caris Life Sciences, that using the ADAPT Biotargeting System, we can create and identify thousand to millions of synthetic molecules and targets simultaneously. This will bind to a wide range of biological targets and characterize complex biological system in their native state, enabling them to profile biological samples at a systems-wide scale. However, factors such as low awareness about these technologies in middle & low income countries and inadequate regulatory structure may restrain the growth of the market. Moreover, continuous advancement in technologies is expected to stimulate new opportunity for the growth of this market.

North America is Expected to Dominate the Global Aptamers Market

The global aptamers market is segmented into North America, Europe, Asia-Pacific and Rest of the World (ROW). North America dominates the aptamers market due to rapid technological advancement and high investment & funding to support the development of aptamers in this region. For Instance, in 2017, Base Pair technologies an U.S. based firm closed a USD 3.2 million Series A-3 financing round. Base Pair provide custom aptamer discovery and development series, as well as a line of catalog aptamers. The company said it would use the financing to acquire new lab instruments and other technology in order to expand its cellular and molecular analysis capabilities, as well as to expand its team. Asia-pacific is also expected to witness a significant growth in the aptamers market due to factors such as increasing research and development activities and economic growth of this region within the forecast period.

Key Benefits for Global Aptamers Market Reports –

Global Aptamers Market report covers in-depth historical and forecast analysis.
Global Aptamers Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
Global Aptamers Market report helps to identify opportunities in marketplace.
Global Aptamers Market report covers extensive analysis of emerging trends and competitive landscape.
Aptamers Market Segmentation:-
By Type:

Nucleic acid aptamers
DNA-based aptamers
RNA-based aptamers
XNA-based aptamers
Peptide aptamers
By Applications:

Diagnostics
Therapeutics Development
Research and Development
Others
By End-Users:

Bio-Pharmaceutical Companies
Pharmaceutical Companies
Academic and Research Centers
Contract Research Organization
By Regional & Country Level:

North America
U.S.
Canada
Europe
UK.
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
Mexico
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa